X
Record #54072

Inhibition of CD73 using folate targeted nanoparticles carrying anti-CD73 siRNA potentiates anticancer efficacy of Dinaciclib

Publisher
Elsevier
Original paper date
Jul 26, 2020
Institution
Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran · Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran · Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran · Department of Genetics, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran · Department of Oncology, Cross Cancer Institute, The University of Alberta, Edmonton, Alberta, Canada · Nanotechnology Research Centre, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran · Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran · Cellular and Molecular Research Center, Cellular and Molecular Medicine Institute, Urmia University of Medical Sciences, Urmia 5714783734, Iran · Cellular and Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, Iran · Division of Surgical Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, USA · Department of Immunology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
Open access
No
Article type
Research Article
Broad categories
(BLS) Biochemistry(BLS) Biology - Cancer(BLS) Biology - Cellular(BLS) Genetics(PHY) Nanotechnology
Notes from Retraction Watch

see also; https://pubpeer.com/publications/ECEAC7F423586089745301BD8209F5#1

Citation lifecycle

How this paper is being cited

Pre-retraction
23
Same day
0
Post-retraction
2
% post-retraction
8.0%
~6.0 citations/yr before retraction · ~0.9 citations/yr after
— citing papers

Who is still citing this work

Loading…
Back to browse